Treatment Modalities in Lung Cancer

Size: px
Start display at page:

Download "Treatment Modalities in Lung Cancer"

Transcription

1 Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer, organised by the International Association for the Study of Lung Cancer (IASLC), Le Havre, June 9-13, 1987 Treatment Modalities in Lung Cancer Volume Editors R. Arriagada, Villejuif T. Le Chevalier, Villejuif Associate Editors J.R. Bertino, New York, N.Y.; N.M. Bleehen, Cambridge; J.H. Goldie, Vancouver; H.H. Hansen, Copenhagen; D.C. Ihde, Bethesda, Md. 40 figures and 50 tables, 1988 Basel Miinchen Paris London New York NewDelhi Singapore Tokyo Sydney

2 List of Participants XI Inaugural Conference Tubiana, M. (Villejuif): The Combination of Radiotherapy and Chemotherapy.. 1 Mathematical Models Goldie, J.H.; Coldman, A.J.; Ng, V. (Vancouver, B.C.); Hopkins, H.A.; Looney, W.B. (Charlottesville, Va.): A Mathematical and Computer-Based Model of Alternating Chemotherapy and Radiation Therapy in Experimental Neoplasms 11 Souhami, R.L.; Gregory, W.M.; Birkhead, B.G. (London): Mathematical Models in High-Dose Chemotherapy 21 Biological Bases and Mechanisms of Cell Resistance to Therapy Bertino, J.R. (New York, N. Y.): Review of Mechanisms of Cell Resistance to Therapy in Lung Cancer 29 Looney, W.B.; Hopkins, H.A. (Charlottesville, Va.): The Relationship of Experimental, Theoretical and Clinical Studies of Alternating Chemotherapy and Radiotherapy in the Management of Lung Cancer 35 Milas, L. (Houston, Tex.): Effects of Radiotherapy and Chemotherapy on Tumor Bed Stroma.." 48

3 VIII Treatment Response Evaluation and Statistical Analysis Sorensen, J.B.; Hansen, H.H. (Copenhagen): Review of Methodological Problems in the Interpretation of Phase II Trials in Nonsmall-Cell Lung Cancer 57 Ihde, D.C. (Bethesda, Md.): How Should We Report Results of Clinical Trials of Combined Chemotherapy and Chest Irradiation in Limited Stage Small Cell Lung Cancer? 65 Choi, N.C.; Carey, R.W. (Boston, Mass.): Reassessment of Loco-Regional Failure Rate in Relation with Radiation Dose in Combined Modality Approach of Multidrug Chemotherapy and Radiotherapy for Limited Stage Small-Cell Lung Carcinoma 70 Souhami, R.L.; Earl, H.M.; Ash, CM.; Spiro, S.G.; Geddes, D.; Harper, P.G.; Tobias, J.S. (London): Prognostic Factors in Patients with Small-Cell Lung Cancer: Preliminary Results from a Large Randomised Study 77 B6nichou, J.; Chastang, C. (Paris): Use of the Triangular Test in the Analysis of Randomized Clinical Trials when the Response Criterion is Censored: Application to Two Trials in Lung Cancer 83 Concurrent Combinations Ihde, D.C; Seifter, E.J.; Johnson, B.E.; Glatstein, E. (Bethesda, Md.): Review of Concurrent Chemotherapy/Radiotherapy Combinations in Small Cell Lung Cancer 92 Payne, D.G.; Feld, R. (Toronto, Ont.): Concurrent Radiotherapy and Chemotherapy in Lung Cancer at the Princess Margaret Hospital 96 Lange, O.F. (Bonn): Concurrent Chemo-Radiotherapy in Small Cell Lung Cancer. 102 Turrisi, A.T.; Glover, D.J.; Mason, B.A. (Philadelphia, Pa.): Concurrent Twice- Daily Radiotherapy Plus Platinum-Etoposide Chemotherapy for the Treatment of Limited Small Cell Lung Cancer: A Preliminary Report 109 Sequential Combinations Bleehen, N.M. (Cambridge): Review of Sequential Radio-Chemotherapy Schedules in the Treatment of Lung Cancer 115 Trovo, M.G.; Veronesi, A.; Bortolus, R.; Roncadin, M.; De Paoli, A.; Franchin, G.; Grigoletto, E.; Minatel, E. (Aviano): Is Chemotherapy Necessary in the Management of Unresectable Nonmetastatic Nonsmall-Cell Lung Cancer? Van Houtte, P.; Klastersky, J. (Brussels); Renaud, A.; Michel, J. (La Louvriere); Vandermoten, G.; Nguyen, H.; Sculier, J.P.; Devriendt, J.; Mommen, P. (Brussels): Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiiiiation Therapy for Nonsmall-Cell Lung Cancer. A Randomized Study. 131 Thomas, F.; Le Chevalier, T.; Arriagada, R.; Ruffie\ P.; Baldeyrou, P. (Villejuif): Should Chemotherapy Response Be Evaluated Separately in Sequential Chemotherapy-Radiotherapy Schedules in Locally Advanced Nonsmall-Cell Lung Carcinoma? 138 Aisner, J. (Baltimore, Md.): Combined Modalities in the Treatment of Small Cell Carcinoma of the Lung. A Review of Current Standings 142

4 IX Unconventional Combinations Arriagada, R. (Villejuif): Review of Unconventional Combinations of Radiotherapy and Chemotherapy in Lung Cancer 150 Souhami, R.L.; Ash, CM.; Earl, H.M.; Harper, P.G.; Geddes, D.; Tobias, J.S.; Spiro, S.G. (London): Intensive Chemotherapy and Thoracic Irradiation as Induction Treatment in Limited-Stage Small-Cell Lung Cancer 155 Dionet, C; Verrelle, P.; Roux, D.; Fraysse, P.; Achard, J.-L.; Beaupain, R.; Rozan, R. (Clermont-Ferrand): Role of Small Doses of Radiotherapy Combined with Chemotherapy in Non-Small Cell Lung Cancer 163 Hurman, D.C; Urtasun, R.C; Belch, A.R.; Kinney, B.; Amy, R.; Hanson, J. (Alberta, Ed.); Feldstein, M. (Boston, Mass.): Sequential Wide Field Irradiation and Systemic Chemotherapy as Part of the Induction Treatment of Small Cell Lung Cancer 168 Looney, W.B.; Hopkins, H.A. (Charlottesville, Va.): The Integration of Multifractionated Radiotherapy into Combined Chemotherapeutic-Radiotherapeutic s Approaches to Lung Cancer Treatment 176 Scher, H.; Gralla, R.; Linares, L.; Kris, M.; Heelan, R.; Shank, B. (New York, N.Y.): Preliminary Results of Combination Chemotherapy and Sequential Accelerated Fractionation Radiation Therapy in Limited-Stage Small Cell Carcinoma of the Lung. Evaluation of Measures for Reduction of Toxicity and Effect on Complete Response Rate 184 Le Chevalier, T.; Arriagada, R.; Thomas, F.; Baldeyrou, P.; Ruffle, P. (Villejuif); Cremoux, H. de; Martin, M. (Creteil); Cerrina, M.L. (Clamart); De The\ H.; Tarayre, M.; Sancho-Garnier, H.; GROP (Villejuif): Experience of the Institut Gustave-Roussy in Alternating Radiotherapy and Chemotherapy Schedules as Induction Treatment in Limited Small-Cell Lung Cancer 190 Arriagada, R.; De Th6, H.; Thomas, F. (Villejuif); Cremoux, H. de (Cr&eil); Dewar, J.; Sancho-Garnier, H.; Le Chevalier, T.; GROP (Villejuif): Prognostic Value of Initial Chemotherapy Doses in Limited Small Cell Lung Cancer 194 Treatment Toxicity and Long-Term Sequelae Le Chevalier, T. (Villejuif): Review of Toxicity and Long-Term Sequelae in Lung Cancer 199 Feld, R.; Payne, D.; Hodson, I.; Coy, P. for the NCI Clinical Trials Group (Toronto, Ont.): Complications of Treatment of Small Cell Carcinoma of the Lung Johnson, B.E.; Glatstein, E.; Ihde, D.C. (Bethesda, Md.): The National Cancer Institute Experience with Early and Late Effects of Combined Modality Therapy in Small Cell Lung Cancer 210 Choi, N.C; Kanarek, D.J.; Kazemi, H. (Boston, Mass.): Prospective Study of Pulmonary Tolerance to Radiotherapy or Radiotherapy plus Multidrug Chemotherapy for Loco-Regional Lung Carcinoma 213 Souhami, R.L.; Morittu, L.; Ash, CM.; Earl, H.; Geddes, D.; Harper, P.G.; Tobias, J.S.; Spiro, S.G. (London): Identification of Patients at High Risk of Chemotherapy-Induced Toxicity in Small-Cell Lung Cancer 220

5 X Kaasa, S.; Olsnes, B.T.; Thorud, E.; Hast, H. (Oslo): Reduced Short-Term Neuropsychological Performance in Patients with Nonsmall-Cell Lung Cancer Treated with Cisplatin and Etoposide 226 Consensus Report Arriagada, R.; Bertino, J.R.; Bleehen, N.M.; Brodin, O.; Feld, R.; Goldie, J.H.; Hansen, H.H.; Ihde, D.C; Le Chevalier, T.; Souhami, R.L. and the Workshop Participants: Consensus Report on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer 232 Subject Index 242

Lung cancer is common and difficult to treat. By

Lung cancer is common and difficult to treat. By Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer A Meta-Analysis Robert S. Pritchard, MD, MS, and Stephen P.

More information

CALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer

CALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000

More information

The New England Journal of Medicine PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION

The New England Journal of Medicine PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION ANNE AUPÉRIN, M.D., RODRIGO ARRIAGADA, M.D., JEAN-PIERRE PIGNON, M.D., PH.D., CÉCILE LE PÉCHOUX, M.D., ANNA

More information

Progress in Experimental Tumor Research

Progress in Experimental Tumor Research COX-2 Progress in Experimental Tumor Research Vol. 37 Series Editor Joseph R. Bertino, New Brunswick, N.J. Basel Freiburg Paris London New York Bangalore Bangkok Singapore Tokyo Sydney COX-2 A New Target

More information

Chemotherapy in Lung Cancer

Chemotherapy in Lung Cancer Special Issue Chemotherapy in Lung Cancer Keunchil Park, M.D. Division of Hematology / Oncology, Department of Medicine Sungkyunkwan University School of Medicine, Samsung Medical Center E-mail : kpark@smc.samsung.co.kr

More information

1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL

1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL Current treatment practices for limited-stage small cell lung cancer: A survey of US radiation oncologists on the timing of thoracic radiotherapy with chemotherapy Matthew J. Farrell 1, Jehan Yahya 1,

More information

Pulmonary function tests 3. Is patient potentially operable? Yes. Inoperable. Yes. Zubrod performance status

Pulmonary function tests 3. Is patient potentially operable? Yes. Inoperable. Yes. Zubrod performance status te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Pathology consistent with SCLC History and physical Chest x-ray Laboratory studies to include hematological and

More information

Original Study. 40 Clinical Lung Cancer January 2013

Original Study. 40 Clinical Lung Cancer January 2013 Original Study Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation Patricia Tai, 1 Avi Assouline, 2 Kurian Joseph, 3 Larry Stitt, 4 Edward

More information

SMALL-CELL CARCINOMA of the lung contributes

SMALL-CELL CARCINOMA of the lung contributes Does Thoracic Irradiation Improve Survival and Local Control in Limited-Stage Small-Cell Carcinoma of the Lung? A Meta-Analysis By P. Warde and D. Payne Purpose: Our main purpose was to determine whether

More information

Pulmonary Complications of Cancer Treatment

Pulmonary Complications of Cancer Treatment Pulmonary Complications of Cancer Beth Zigmund, MD Objectives (Preliminary Version) Beth Zigmund, MD Develop awareness of the myriad pulmonary complications of cancer treatment and of challenge in making

More information

Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón

Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Santiago Ponce Aix Servicio Oncología Médica Hospital Universitario 12 de Octubre Madrid Stage III: heterogenous disease

More information

The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer

The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Evidence-based Series # 7-13-3 EDUCATION AND INFORMATION 2013 The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Members of the Lung Cancer

More information

The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer

The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer Curr. Treat. Options in Oncol. (2015) 16: 56 DOI 10.1007/s11864-015-0372-2 Lung Cancer (HA Wakelee, Section Editor) The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer Kaname Nosaki, M.D.

More information

Introduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770

Introduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770 Original Article Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival David Schreiber, MD,* Andrew T. Wong, MD,* David Schwartz, MD,* and Justin Rineer, MD Introduction:

More information

Body Image, Self-Esteem, and Sexuality in Cancer Patients

Body Image, Self-Esteem, and Sexuality in Cancer Patients Body Image, Self-Esteem, and Sexuality in Cancer Patients Frontiers of Radiation Therapy and Oncology Vo1.14 Series Editor Jerome M. Vaeth, San Francisco, Calif. Associate Editors Jerold P. Green, Alan

More information

M. A. SOCINSKI, L.B. MARKS, J. GARST, G.S. SIBLEY, W. BLACKSTOCK, A. TURRISI, J. HERNDON, S. ZHOU, M. ANSCHER, J. CRAWFORD, T. SHAFMAN, J.

M. A. SOCINSKI, L.B. MARKS, J. GARST, G.S. SIBLEY, W. BLACKSTOCK, A. TURRISI, J. HERNDON, S. ZHOU, M. ANSCHER, J. CRAWFORD, T. SHAFMAN, J. Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal

More information

Thymic Tumors KARGER. 7th Cancer Research Workshop, Grenoble, October 15-17, Editors R. Sarrazin, C. Vrousos, F.

Thymic Tumors KARGER. 7th Cancer Research Workshop, Grenoble, October 15-17, Editors R. Sarrazin, C. Vrousos, F. Thymic Tumors 7th Cancer Research Workshop, Grenoble, October 15-17, 1987 Thymic Tumors Editors R. Sarrazin, C. Vrousos, F. Vincent, Grenoble 52 figures and 39 tables, 1989 KARGER Basel München Paris

More information

Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?

Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again? Editorial Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again? Cecile Le Pechoux 1, Angela Botticella 1, Antonin

More information

Clinical Management Guideline for Small Cell Lung Cancer

Clinical Management Guideline for Small Cell Lung Cancer Diagnosis and Staging: Key Points 1. Ensure a CT scan that is

More information

Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer (SCLC) te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Small Cell Lung Cancer (SCLC) Page 1 of 8 STAGE FURTHER ASSESSMENT Pathology consistent with SCLC History and

More information

Combined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer

Combined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer Journal of BUON 7: 47-51, 2002 2002 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Combined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer S. Isaković-Vidović,

More information

Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer

Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer Original Article Radiat Oncol J 2013;31(4):185-190 http://dx.doi.org/10.3857/roj.2013.31.4.185 pissn 2234-1900 eissn 2234-3156 Effect of early chemoradiotherapy in patients with limited stage small cell

More information

of the United Kingdom Coordinating Committee on Cancer Research

of the United Kingdom Coordinating Committee on Cancer Research '." Br. J. Cancer Cancer (1990), (1990), 61, 597-604 Macmillan Press Ltd., 1990 61, 597-604 Macmillan Press Ltd., 1990~~~~~ An overview of prognostic factors in small cell lung cancer A report from the

More information

RESEARCH ARTICLE. Evrim Bayman 1 *, Durmus Etiz 1, Melek Akcay 1, Guntulu Ak 2. Abstract. Introduction

RESEARCH ARTICLE. Evrim Bayman 1 *, Durmus Etiz 1, Melek Akcay 1, Guntulu Ak 2. Abstract. Introduction DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6263 RESEARCH ARTICLE Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution

More information

KAR.GER. Antibiotics and Chemotherapy. Vol. 45. Series Editor H. SchOnfeld, Grenzach

KAR.GER. Antibiotics and Chemotherapy. Vol. 45. Series Editor H. SchOnfeld, Grenzach Bacterial Meningitis Antibiotics and Chemotherapy Vol. 45 Series Editor H. SchOnfeld, Grenzach KAR.GER. Basel Miinchen Paris London New York. New Delhi Bangkok Singapore Tokyo Sydney Bacterial Meningitis

More information

Emesis in Anti-cancer Therapy Mechanisms and treatment

Emesis in Anti-cancer Therapy Mechanisms and treatment Emesis in Anti-cancer Therapy Mechanisms and treatment Edited by P.L.R. Andrews Reader in Physiology St George's Hospital Medical School London UK and G.J. Sanger Director of Gastrointestinal Research

More information

Accepted Manuscript. Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD

Accepted Manuscript. Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD Accepted Manuscript Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD PII: S0022-5223(18)31821-X DOI: 10.1016/j.jtcvs.2018.06.069 Reference: YMTC 13198 To appear in: The

More information

Before any medical interventions are undertaken in patients

Before any medical interventions are undertaken in patients ORIGINAL ARTICLE Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer Yuko Minami-Shimmyo, MD,* Yuichiro Ohe, MD, PhD,* Seiichiro Yamamoto, PhD,

More information

Combined modality treatment for N2 disease

Combined modality treatment for N2 disease Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical

More information

FREQUENCY OF THORACIC RADIOTHERAPY WITH CHEMOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER

FREQUENCY OF THORACIC RADIOTHERAPY WITH CHEMOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER TWICE-DAILY COMPARED WITH ONCE-DAILY THORACIC RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER TREATED CONCURRENTLY WITH CISPLATIN AND ETOPOSIDE ANDREW T. TURRISI, III, M.D., KYUNGMANN KIM, PH.D., RONALD

More information

OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER

OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER Author Chayawut Punsriwong Chayakamon Niyasom Pariphat Chompoonutprapa Sarut Pravitkulawath 5 th year medical student Naresuan University

More information

THORACIC MALIGNANCIES

THORACIC MALIGNANCIES THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,

More information

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma ORIGINAL ARTICLE Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma Nader Abedallaa, MD,* Lise Tremblay, MD, Charlotte Baey,* Dominique Fabre, MD, David

More information

SUMMARY OF CHANGES Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10

SUMMARY OF CHANGES Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10 Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10 RTOG 0239, "A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell

More information

Chemotherapy in lung cancer

Chemotherapy in lung cancer Postgraduate Medical Journal (1989) 65, 291-298 Difficult Decisions Chemotherapy in lung cancer C.G.A. Price and M.L. Slevin I.C.R.F. Department ofmedical Oncology, St Bartholomew's and Homerton Hospitals,

More information

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer British Journal of Cancer (1999) 79(9/10), 1462 1467 1999 Cancer Research Campaign Article no. bjoc.1998.0233 Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced

More information

When approaching a patient with inoperable non-small

When approaching a patient with inoperable non-small ORIGINAL ARTICLE Gemcitabine, Cisplatin, and Hyperfractionated Accelerated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Matjaz Zwitter, PhD, MD, Viljem Kovac, MSc, MD, Uros Smrdel, MD,

More information

Past, present and future of Radiotherapy of Lung Cancer

Past, present and future of Radiotherapy of Lung Cancer Past, present and future of Radiotherapy of Lung Cancer Joaquin G Mira MD, FACR START center Clinical professor, Univers. Texas Health Science Center, San Antonio, Texas Small cell lung cancer past, present

More information

MOLECULAR AND CLINICAL ONCOLOGY 2:

MOLECULAR AND CLINICAL ONCOLOGY 2: MOLECULAR AND CLINICAL ONCOLOGY 2: 805-810 A meta analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy

More information

Place de la radiothérapie dans les CBPC métastatiques

Place de la radiothérapie dans les CBPC métastatiques Place de la radiothérapie dans les CBPC métastatiques Cecile Le Péchoux, 12 ème Biennale Monégasque de Cancérologie, 2016 IOT Institut d Oncologie Thoracique CBPC metastatique Rapid doubling time, early

More information

Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010

Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010 Prophylactic Cranial Irradiation in Lung Cancer Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010 Prophylactic cranial irradiation PCI was introduced

More information

Small-cell lung cancer (SCLC) is an aggressive neuroendocrine

Small-cell lung cancer (SCLC) is an aggressive neuroendocrine ORIGINAL ARTICLE Tolerability of Accelerated Chest Irradiation and Impact on Survival of Prophylactic Cranial Irradiation in Patients with Limited-stage Small Cell Lung Cancer: Review of a Single Institution

More information

Management of advanced non small cell lung cancer

Management of advanced non small cell lung cancer Management of advanced non small cell lung cancer Jean-Paul Sculier Intensive Care & Thoracic Oncology Institut Jules Bordet Université Libre de Bruxelles (ULB) www.pneumocancero.com Declaration No conflict

More information

Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer

Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer 2654 Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer GUOQIN QIU, XIANGHUI DU, XIA ZHOU, WUAN BAO, LEI CHEN, JIANXIANG CHEN, YONGLING JI and SHENGYE WANG Department

More information

5/20/ ) Haffty GB: Concurrent chemoradiation in the treatment of head and neck cancer. Hematol. Oncol. Clin: North Am.

5/20/ ) Haffty GB: Concurrent chemoradiation in the treatment of head and neck cancer. Hematol. Oncol. Clin: North Am. Prague, 24-25 25 April 29 ALTERNATING CHEMORADIATION: FOR WHOM? M. Merlano MD Holy Cross Gen. Hospital Cuneo - Italy ALTERNATING CHEMORADIATION: FOR WHOM? Definition of alternating chemoradiation Targets

More information

Chemotherapy Treatment Algorithms for Urology Cancer

Chemotherapy Treatment Algorithms for Urology Cancer Chemotherapy Treatment Algorithms for Urology Cancer Chemoradiation for bladder cancer; Chemotherapy algorithm for non TCC bladder cancer Squamous cell carcinoma; Chemotherapy Algorithm for Non Transitional

More information

REVIEW ARTICLE. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer

REVIEW ARTICLE. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer REVIEW ARTICLE Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer Kate Haslett 1, Christoph Pöttgen 2, Martin Stuschke 2, Corinne Faivre-Finn 1,3 1 Radiotherapy Related Research,

More information

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Dr. Sause: Clinical, Research, and Administration Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Objectives: Identify Dr. Sause's educational achievements Discuss

More information

Single Technology Appraisal (STA)

Single Technology Appraisal (STA) Single Technology Appraisal (STA) Durvalumab for maintenance treatment of locally advanced unresectable non-small cell lung cancer that has not progressed after platinum-based chemoradiation therapy Response

More information

Stage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99

Stage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99 Stage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99 Introduction 1/3 of the total lung cancer cases few patients are cured with single modality

More information

SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)

SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Desiree Hao (Staff Medical Oncologist, University of Calgary) and Dr.

More information

Basel München Paris London New York NewDelhi Singapore - Tokyo Sydney

Basel München Paris London New York NewDelhi Singapore - Tokyo Sydney Endocrine Management of Cancer 2 Contemporary Therapy Basil A. Stoll, London (Editor) Endocrine Management of Cancer 2 Contemporary Therapy 3 figures and 20 tables, 1988 KARGER Basel München Paris London

More information

NSCLC: Staging & Prognosis. Neoadjuvant chemotherapy. Controversies in the management of early NSCLC: neoadjuvant vs adjuvant chemotherapy

NSCLC: Staging & Prognosis. Neoadjuvant chemotherapy. Controversies in the management of early NSCLC: neoadjuvant vs adjuvant chemotherapy Controversies in the management of early NSCLC: neoadjuvant vs adjuvant Sarita Dubey sst Professor, Medical ncology, UCSF NSCLC: Staging & Prognosis Pathologic Survival elapse (%) Stage 5 yr (%) Local

More information

Self-Assessment Module 2016 Annual Refresher Course

Self-Assessment Module 2016 Annual Refresher Course LS16031305 The Management of s With r. Lin Learning Objectives: 1. To understand the changing demographics of oropharynx cancer, and the impact of human papillomavirus on overall survival and the patterns

More information

Case presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium

Case presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Case presentation Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Perspectives in Lung Cancer Brussels 6-7 march 2009 LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery

More information

Quality of meta-analyses and why they sometimes lead to different conclusions

Quality of meta-analyses and why they sometimes lead to different conclusions Quality of meta-analyses and why they sometimes lead to different conclusions Jean-Pierre Pignon, MD, PhD Service de Biostatistique et d Epidémiologie, Ligue Nationale Contre le Cancer metaanalysis platform,

More information

Outcome of nonsurgical treatment for locally advanced thymic tumors

Outcome of nonsurgical treatment for locally advanced thymic tumors Original Article Outcome of nonsurgical treatment for locally advanced thymic tumors Chang-Lu Wang 1, Lan-Ting Gao 1, Chang-Xing Lv 1, Lei Zhu 2, Wen-Tao Fang 3 1 Department of Radiation Oncology, 2 Department

More information

Concurrent and sequential chemoradiotherapy. P. Van Houtte Department of Radiation Oncology Institut Jules Bordet

Concurrent and sequential chemoradiotherapy. P. Van Houtte Department of Radiation Oncology Institut Jules Bordet Concurrent and sequential chemoradiotherapy and radiotherapy for NSCLC P. Van Houtte Department of Radiation Oncology Institut Jules Bordet RADIOTHERAPY & CHEMOTHERAPY A very old concept «Benzene could

More information

PROCARBAZINE, lomustine, and vincristine (PCV) is

PROCARBAZINE, lomustine, and vincristine (PCV) is RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine

More information

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Cent. Eur. J. Med. 9(2) 2014 279-284 DOI: 10.2478/s11536-013-0154-9 Central European Journal of Medicine Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Jacopo Giuliani* 1, Marina

More information

Causes of Treatment Failure and Death in Carcinoma of the Lung

Causes of Treatment Failure and Death in Carcinoma of the Lung THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 201-207 Causes of Treatment Failure and Death in Carcinoma of the Lung JAMES D. COX, M.D.,a AND RAYMOND A. YESNER, M.D.b The Medical College of Wisconsin,

More information

Update on Small Cell Lung Cancer

Update on Small Cell Lung Cancer Welcome to Master Class for Oncologists Session 4: 10:00 AM - 10:45 AM San Francisco, CA October 23, 2009 Speaker: Bruce E. Johnson, MD Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer

Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer C. Wu, T. Wang, J. Wang, B. Qu, H. Wang and Y. Hu Department of Oncology, The General Hospital of the People

More information

Practice changing studies in lung cancer 2017

Practice changing studies in lung cancer 2017 1 Practice changing studies in lung cancer 2017 Rolf Stahel University Hospital of Zürich Cape Town, February 16, 2018 DISCLOSURE OF INTEREST Consultant or Advisory Role in the last two years I have received

More information

Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results

Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results British Journal of Cancer (2002) 87, 562 566 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response

More information

The role of prophylactic brain irradiation in small cell lung cancer treatment

The role of prophylactic brain irradiation in small cell lung cancer treatment Monaldi Arch Chest Dis 2003; 59: 2, 128-133 REVIEW The role of prophylactic brain irradiation in small cell lung cancer treatment J.B. Sørensen ABSTRACT: The role of prophylactic brain irradiation in small

More information

RTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman

RTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman RTOG Lung Cancer Committee 2012 Clinical Trial Update Wally Curran RTOG Group Chairman 1 RTOG Lung Committee: Active Trials Small Cell Lung Cancer Limited Stage (Intergroup Trial) Extensive Stage (RTOG

More information

Multimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach

Multimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach Perspective Multimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach Valentina Polo 1,2, Giulia Pasello 1 1 Medical Oncology 2, Venetian Oncology

More information

Lung cancer is the leading cause of cancer-related death in

Lung cancer is the leading cause of cancer-related death in ORIGINAL ARTICLE Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice Christophe Massard, MD,* Pierre Tran Ba Loc, MD, Vincent Haddad, MS, Jean-Pierre Pignon, MD, Philippe Girard,

More information

Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients

Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients Original article Annals of Oncology 13: 748 754, 2002 DOI: 10.1093/annonc/mdf123 Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients

More information

Central Nervous System Involvement and the Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer

Central Nervous System Involvement and the Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer Central Nervous System Involvement and the Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer C.G. ALEXOPOULOS, M. VASLAMATZIS, E. PATILA, L. TARANTO Department of Medical Oncology, Evangelismos

More information

Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas

Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas Critical Reviews in Oncology/Hematology 56 (2005) 353 364 Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas Jacques Bernier a,, David G. Pfister b, Jay S. Cooper

More information

A PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG

A PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG Original Article A PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG Naeem Haider 1, Shaharyar 2, Shahid Rasul

More information

Basel Mnchen Paris London NewYork NewDelhi Bangkok Singapore Tokyo Sydney

Basel Mnchen Paris London NewYork NewDelhi Bangkok Singapore Tokyo Sydney 19 Advances in Psychosomatic Medicine Editor: T.N. Wise Issues in Geriatric Psychiatry Editors : N. Billig, P.V. Rabins Issues in Geriatric Psychiatry Advances in Psychosomatic Medicine Vol. 19 Series

More information

Disclosure SBRT. SBRT for Spinal Metastases 5/2/2010. No conflicts of interest. Overview

Disclosure SBRT. SBRT for Spinal Metastases 5/2/2010. No conflicts of interest. Overview Stereotactic Body Radiotherapy (SBRT) for Recurrent Spine Tumors Arjun Sahgal M.D., F.R.C.P.C. Assistant Professor Princess Margaret Hospital Sunnybrook Health Sciences Center University of Toronto Department

More information

Lung Cancer Study Stage at diagnosis Days to first treatment First course of treatment Cancer Review Committee

Lung Cancer Study Stage at diagnosis Days to first treatment First course of treatment Cancer Review Committee Lung Cancer Study 2000-2011 Stage at diagnosis Days to first treatment First course of treatment Cancer Review Committee Stage of diagnosis of lung, bronchus non-small cell carcinoma cancer diagnosed in

More information

Accepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD

Accepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD Accepted Manuscript Risk stratification for distant recurrence of resected early stage NSCLC is under construction Michael Lanuti, MD PII: S0022-5223(17)32392-9 DOI: 10.1016/j.jtcvs.2017.10.063 Reference:

More information

Debate 1 Are treatments for small cell lung cancer getting better? No:

Debate 1 Are treatments for small cell lung cancer getting better? No: Debate 1 Are treatments for small cell lung cancer getting better? No: Taofeek Owonikoko, MD, PhD Associate Professor Department of Hematology & Medical Oncology Winship Cancer Institute of Emory University

More information

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis D. De Ruysscher, B. Lueza, C. Le Péchoux, H. Johnson, M. O Brien,

More information

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy

More information

Accepted 28 April 2005 Published online 13 September 2005 in Wiley InterScience ( DOI: /hed.

Accepted 28 April 2005 Published online 13 September 2005 in Wiley InterScience (  DOI: /hed. DEFINING RISK LEVELS IN LOCALLY ADVANCED HEAD AND NECK CANCERS: A COMPARATIVE ANALYSIS OF CONCURRENT POSTOPERATIVE RADIATION PLUS CHEMOTHERAPY TRIALS OF THE EORTC (#22931) AND RTOG (#9501) Jacques Bernier,

More information

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION

More information

Combined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc

Combined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc Combined drug and ionizing radiation: biological basis Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc Pelvic radiation with concurrent chemotherapy compared with

More information

Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer

Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer - Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer Margaret A. Tucker, Nevin Murray, Edward G. Shaw, David S. Ettinger, Mack Mabry, Martin H. Huber, Ronald Feld, Frances

More information

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation

More information

Radiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer

Radiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer J Lung Cancer 2011;10(1):37-43 Radiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer Purpose: To retrospectively evaluate the outcomes and complications of curative radiotherapy for locoregionally

More information

Brain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment

Brain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment 605 Brain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment Risk Factors Analysis Giovanni Luca Ceresoli, M.D. 1 Michele Reni, M.D. 1 Giuseppe Chiesa, M.D. 2 Angelo

More information

Longcarcinoom: Literatuur en referenties

Longcarcinoom: Literatuur en referenties 7.9.9. Longcarcinoom: Literatuur en referenties 1. Niet-invasieve stadiëring longcarcinoom - American Thoracic Society (ATS), European Respiratory Society (ERS). Pretreatment evaluation of non-small cell

More information

Schizophrenia: Positive and Negative Symptoms and Syndromes

Schizophrenia: Positive and Negative Symptoms and Syndromes Schizophrenia: Positive and Negative Symptoms and Syndromes Modern Problems of Pharmacopsychiatry Founded 1968 by F.A. Freyhant, N. Petrilowitscht, and P. Pichot Vol. 24 Series Editors T.A. Ban, Nashville,

More information

Câncer de Pulmão Não Pequenas Células

Câncer de Pulmão Não Pequenas Células Câncer de Pulmão Não Pequenas Células Carboplatina + Paclitaxel Paclitaxel: 200mg/m 2 IV D1 Carboplatina: AUC 6 IV D1 a cada 21 dias X 4 ciclos Ref. (1) Vinorelbina + Cisplatina Vinorelbina: 25mg/m 2 IV

More information

Combined modality treatment for NSCLC with N2 disease

Combined modality treatment for NSCLC with N2 disease Combined modality treatment for NSCLC with N2 disease Gerry Hanna Senior Lecturer and Consultant in Clinical Oncology Centre for Cancer Research and Cell Biology @gerryhanna E: g.hanna@qub.ac.uk Talk Outline

More information

THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra,

THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra, THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra, Slovakia Lancet. 1966;2(7471):979-86. First standard treatment:

More information

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer*

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer* Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer* Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group William

More information

SMALL CELL LUNG CANCER Updated June 2018 by Dr. Kirstin Perdrizet (PGY-5 Medical Oncology Resident, University of Toronto)

SMALL CELL LUNG CANCER Updated June 2018 by Dr. Kirstin Perdrizet (PGY-5 Medical Oncology Resident, University of Toronto) SMALL CELL LUNG CANCER Updated June 2018 by Dr. Kirstin Perdrizet (PGY-5 Medical Oncology Resident, University of Toronto) Reviewed by Dr. Adrian Sacher (Staff Medical Oncologist, Princess Margaret Cancer

More information

Targeted Radiation +/- Biologics News Briefing

Targeted Radiation +/- Biologics News Briefing Targeted Radiation +/- Biologics News Briefing Wednesday, October 31, 2012 7:00 a.m. 7:45 a.m. Catherine Park, MD Vice-chairman of the ASTRO Education Committee Eric Chang, MD ASTRO Annual Meeting Scientific

More information

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately

More information

Combined Modality Therapy State of the Art. Everett E. Vokes The University of Chicago

Combined Modality Therapy State of the Art. Everett E. Vokes The University of Chicago Combined Modality Therapy State of the Art Everett E. Vokes The University of Chicago What we Know Some patients are cured (20%) Induction and concurrent chemoradiotherapy are each superior to radiotherapy

More information

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER KHANH NGUYEN, MD, MA DEPARTMENT OF RADIATION ONCOLOGY BAYHEALTH CANCER CENTER BREAST CANCER STATISTICS Most common

More information